| Patents for C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877) |
|---|
| 04/06/2005 | EP1090011A4 Inhibitors of prenyl-protein transferase |
| 04/06/2005 | CN1195514C Metabolites of ecteinascidin 743 |
| 03/30/2005 | EP1235831B1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/24/2005 | WO2004108090A3 Process for manufacturing oxycodone |
| 03/24/2005 | WO2004094371A3 Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity |
| 03/15/2005 | US6867334 Treating mammalian leukemia; lung carcinoma; colon adenocarcinoma malignant melanoma; assaying the human cytochrome CYP3A4 metabolism of ecteinascidin 743 |
| 03/08/2005 | US6864370 From codeine; oxidation, enolization |
| 03/03/2005 | CA2533435A1 Mitotic kinesin inhibitors |
| 03/02/2005 | EP1077698B1 Metabolites of ecteinascidin 743 |
| 02/24/2005 | US20050043308 Process for total synthesis of ecteinascidins and intermediates therefor |
| 02/22/2005 | US6858620 For therapy of male erectile dysfunction; female arousal disorder |
| 02/17/2005 | US20050038251 Process for manufacturing opioid analgesics |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 01/12/2005 | EP1496060A1 Antitumoral analogs of ET-743 |
| 01/12/2005 | CN1564822A Antitumoral analogs |
| 01/06/2005 | US20050004018 Use of antitumoral compound in cancer therapy |
| 12/16/2004 | WO2004108090A2 Process for manufacturing oxycodone |
| 12/07/2004 | US6828327 Macroheterocylic compounds useful as kinase inhibitors |
| 12/01/2004 | CN1551885A Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
| 11/24/2004 | EP1185536B1 Hemisynthetic method and intermediates thereof |
| 11/18/2004 | WO2004028454A3 1, 3, 5-triazines for treatment of viral diseases |
| 11/17/2004 | EP1289999B1 Antitumoral analogs of et-743 |
| 11/04/2004 | WO2004094371A2 Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity |
| 11/04/2004 | CA2521625A1 Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity |
| 11/03/2004 | EP1472261A2 The synthesis of naturally occuring ecteinascidins and related compounds |
| 10/27/2004 | EP1471068A1 Process for total synthesis of ecteinascidins and intermediates therefor |
| 10/21/2004 | WO2004089936A1 Heteroarylsulfonanilide derivative and medicinal composition containing the same |
| 10/20/2004 | EP1467735A2 Polymorphs of clopidogrel hydrogensulfate |
| 09/02/2004 | US20040171605 Benzoxazepines derivatives and their use as ampa receptor stimulators |
| 08/19/2004 | WO2004069844A1 Novel tricyclic oxazepine derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 08/19/2004 | WO2004069843A1 Novel tricyclic azepine derivatives, method for production therof and pharmaceutical compositions comprising the same |
| 08/19/2004 | CA2513059A1 Novel tricyclic azepine derivatives, method for production therof and pharmaceutical compositions comprising the same |
| 08/12/2004 | WO2004054504A3 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 08/10/2004 | US6774126 Pyrrolo[1,2-b][1,2,4]oxadiazine diones useful as nitric oxide synthase inhibitors |
| 07/28/2004 | CN1515674A Biological pure culture for Nocardia |
| 07/21/2004 | CN1514835A Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 07/14/2004 | EP1435988A1 Improved use of antitumoral compound in cancer therapy |
| 07/14/2004 | CN1157189C Semi-synthetic ecteinascidins |
| 07/07/2004 | EP1434585A1 Alkyne matrix metalloproteinase inhibitors |
| 07/01/2004 | WO2004054504A2 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | US20040127436 1,3,5-Triazines for treatment of viral diseases |
| 07/01/2004 | CA2509665A1 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 06/30/2004 | EP1432734A1 Cytokine receptor |
| 06/02/2004 | EP1423393A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
| 05/13/2004 | WO2004039809A1 Novel quinoxaline derivatives |
| 05/12/2004 | CN1149214C Triazolo gerivatives and chemokine inhibitors containing the same as the active ingredient |
| 05/06/2004 | EP1414828A1 Antitumoral analogs |
| 04/29/2004 | US20040082787 Chemical compounds |
| 04/14/2004 | EP1406907A1 New antitumoral derivatives of et-743 |
| 04/08/2004 | WO2004028454A2 1, 3, 5-triazines for treatment of viral diseases |
| 04/08/2004 | CA2499036A1 1,3,5-triazines for treatment of viral diseases |
| 03/25/2004 | US20040059112 Antiproliferative/antitumor agents; veterinary medicine |
| 03/24/2004 | EP1399450A1 Benzoxazepine derivatives and their use as ampa receptor stimulators |
| 03/17/2004 | EP0925301B1 Highly lipophilic camptothecin derivatives |
| 03/11/2004 | WO2004020443A1 Method for manufacturing crystalline form i of clopidogrel hydrogen sulphate |
| 03/11/2004 | CA2495823A1 Method for manufacturing crystalline form i of clopidogrel hydrogen sulphate |
| 02/26/2004 | US20040039197 Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals |
| 01/29/2004 | US20040019056 Anititumoral analogs of et-743 |
| 01/29/2004 | US20040019019 Administering a bicyclic or tricyclic amidino derivative compounds for the treatment of diseases mediated by nitric oxide synthase |
| 01/07/2004 | CN1133437C Nocathiacin antibiotics |
| 01/01/2004 | US20040002602 Synthetic process for the manufacture of an ecteinaschidin compound |
| 12/18/2003 | WO2003066638A3 The synthesis of naturally occuring ecteinascidins and related compounds |
| 11/26/2003 | EP1363630A2 Kappa opioid receptor ligands |
| 11/20/2003 | US20030216397 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent |
| 11/12/2003 | EP1360337A1 Ecteinascidin family compounds: compositions and methods |
| 09/24/2003 | EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors |
| 09/10/2003 | CN1441805A Antitumoral analogue of Et-743 |
| 09/03/2003 | CN1440414A Synthesis of cuttlefish compound |
| 08/26/2003 | US6610722 Inhibitors of prenyl-protein transferase |
| 08/20/2003 | EP1335923A2 Condensed pyridoindole derivatives |
| 08/14/2003 | WO2003066638A2 The synthesis of naturally occuring ecteinascidins and related compounds |
| 08/14/2003 | US20030153564 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 08/14/2003 | CA2749205A1 The synthesis of naturally occurring ecteinascidins and related compounds |
| 08/13/2003 | CN1436193A Antitumoral ecteinascidin derivs |
| 08/07/2003 | WO2003064432A1 Process for total synthesis of ecteinascidins and intermediates therefor |
| 08/07/2003 | WO2003051362A3 Polymorphs of clopidogrel hydrogensulfate |
| 07/31/2003 | US20030144274 Preferential enzyme inhibitors such as 3-(4-Methoxyphenyl)-prop-1-ynyl)-N-(4-carboxybenzyl)benzamide, used for prophylaxis of degenerative diseases including cancer and arthritis |
| 06/26/2003 | WO2003051362A2 Polymorphs of clopidogrel hydrogensulfate |
| 06/26/2003 | CA2470479A1 Polymorphs of clopidogrel hydrogensulfate |
| 05/15/2003 | WO2003039571A1 Improved use of antitumoral compound in cancer therapy |
| 05/15/2003 | CA2462502A1 Improved use of antitumoral compound in cancer therapy |
| 05/07/2003 | CN1107678C Highly lipophilic camptothcin derivatives, its prepn. method and uses |
| 05/06/2003 | US6559303 Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical |
| 05/06/2003 | US6559143 Class III electrophysiological activity, drugs which prolong the trans-membrane action potential duration and refractoriness, without affecting cardiac conduction |
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078280 Macroheterocylic compounds useful as kinase inhibitors |
| 04/24/2003 | CA2462442A1 Alkyne matrix metalloproteinase inhibitors |
| 04/22/2003 | US6552052 Pyrrolo[2,1-c][1,2,4] thiadiazoles and Pyrollo[2,1-c][1,12,4]oxadiazoles useful as nitric oxide synthase inhibitors |
| 03/27/2003 | WO2003025017A1 Cytokine receptor |
| 03/27/2003 | CA2460151A1 Cytokine receptor |
| 03/13/2003 | WO2003020731A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
| 03/13/2003 | CA2458399A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
| 03/12/2003 | EP1289999A1 Antitumoral analogs of et-743 |
| 03/05/2003 | EP1287004A1 Synthetic process for the manufacture of an ecteinascidin compound |
| 02/27/2003 | WO2002028865A3 Condensed pyridoindole derivatives |
| 02/26/2003 | CN1399639A New oxabispidine compound useful in treatment of cardiac arrhythmias |
| 02/20/2003 | WO2003014127A1 Antitumoral analogs |
| 02/19/2003 | EP0931083B1 Process for producing ecteinascidin compounds |
| 02/05/2003 | EP1280809A1 Antitumoral ecteinascidin derivatives |
| 01/30/2003 | WO2003008423A1 New antitumoral derivatives of et-743 |